Neuropsychiatric Adverse Reactions to Mefloquine: a Systematic Comparison of Prescribing and Patient Safety Guidance in the US, UK, Ireland, Australia, New Zealand, and Canada

INTRODUCTION: The antimalarial drug mefloquine (MQ) is associated with neuropsychiatric adverse reactions, some of which may predict the development of more serious effects. Although prescribing guidance in the United States drug label (DL) recommends to discontinue MQ at the onset of neuropsychiatr...

Descripción completa

Detalles Bibliográficos
Autores principales: Nevin, Remington L., Byrd, Aricia M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4919134/
https://www.ncbi.nlm.nih.gov/pubmed/27240849
http://dx.doi.org/10.1007/s40120-016-0045-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4919134/
https://www.ncbi.nlm.nih.gov/pubmed/27240849
http://dx.doi.org/10.1007/s40120-016-0045-5

Ejemplares similares